Drug
Mefenamic Acid clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2017 (3)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2017 | 3 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 3
Takeda (1) · Egymedicalpedia (1) · Sanofi (1) · Assiut University (1) · Hanan Nabil (1) · Bayer (1) · Mahidol University (1)
Often tested with
Tested in the same studies.
Itraconazole (1) · Sotagliflozin (1) · Medroxyprogesterone Acetate (1) · Medroxyprogesterone (1) · Tranexamic Acid (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Mefenamic Acid is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy AdultsCompletedPhase 1TakedaNCT05064449Written as Mefenamic acid
- Management of Abnormal Uterine BleedingCompletedNot applicableEgymedicalpediaNCT06369012Written as Mefenamic acid 500 mg
- Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female SubjectsCompletedPhase 1SanofiNCT03070678Written as Mefenamic acid
- Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic CauseCompletedPhase 3Assiut UniversityNCT02943655Written as mefenamic acid (ponstan forte)
- Preemptive Analgesia for Primary DysmenorrhoeaCompletedPhase 2/3Hanan NabilNCT03323671Written as preemptive mefenamic acid
- Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)CompletedPhase 4BayerNCT01295294Written as Mefenamic acid
- The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary DysmenorrheaCompletedPhase 4Mahidol UniversityNCT01598012Written as Ayurved Siriraj Prasaplai with or without mefenamic acid
Given in every arm · 4 — Mefenamic Acid is usual care beside what is tested
- Efficacy of Different Drugs to Control Post Root Canal Treatment PainCompletedPhase 2University of KhartoumNCT02417337Written as Mefenamic Acid
- Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in WomenCompletedPhase 4Nishtar Medical UniversityNCT07466342Written as Mefenamic acid
- A Trial Investigating Lu AF28996 in Healthy Adult ParticipantsCompletedPhase 1H. Lundbeck A/SNCT06277609Written as Mefenamic Acid
- Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active MetaboliteCompletedPhase 1Emalex Biosciences Inc.NCT04902105Written as Mefenamic acid
As the comparator · 2 — what is tested is compared with Mefenamic Acid
- DLBS1442 for The Treatment of Pain in Patients Suspected EndometriosisCompletedPhase 2/3Dexa Medica GroupNCT01942122Written as Mefenamic acid
- Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With DysmenorrheaCompletedPhase 2Boehringer IngelheimNCT02183025Written as Mefenamic acid 500 mg
Codes
What other systems call Mefenamic Acid · ClinicalTrials.gg INT007779
- MeSH (NLM) D008528Mefenamic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 367589PJ2CMEFENAMIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 6693Confirmed FDA, Wikidata
- Wikidata Q284321mefenamic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47599Mefenamic AcidOne source FDA
- DrugBank DB00784One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008528 | Mefenamic Acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 367589PJ2C | MEFENAMIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6693 | — | Confirmed FDA, Wikidata |
| Wikidata | Q284321 | mefenamic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47599 | Mefenamic Acid | One source FDA |
| DrugBank | DB00784 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.